You are here

FDA's MedWatch Updates

Viramune (nevirapine) - FDA issued a public health advisory to inform health care providers and patients about recent safety-related changes to the nevirapine (Viramune) label and about appropriate use of HIV triple combination therapy containing nevirapine.
(Posted 01/19/2005)

Methylin CT (Methylphenidate HCl Chewable Tablets) - Recall of one lot due to health risk associated with excess active ingredient in product.
(Posted 01/19/2005)

Aranesp (darbepoetin alfa) - WARNINGS and PRECAUTIONS sections revised to include reports of increased mortality and thrombotic vascular events.
(Posted 01/14/2005)

Source: MedWatch, the FDA Safety Information and Adverse Event Reporting Program

Recent Headlines

Rationing, canceled treatments, and fearful patients
Your heart will thank you
Seems like the 2013 Guidelines are having an impact
Biomarker blood tests pick up subtle clues
Meeting 'zombie cells' along the way
A new 'road map' might make it easier
New drug addresses bacterial resistance to standard therapy
Hovering flights lower packages by cable and winch